Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2014
Pathologic complete response as a potential surrogate for the clinical outcome in patients with breast cancer after neoadjuvant therapy: a meta-regression of 29 randomized prospective studiesAlfredo Berruti, Vito Amoroso, Fabio Gallo, et al.
Oncology|July 24, 2018
Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective StudyRebecca Pedersini, Lucia Vassalli, Melanie Claps, et al.
Frontiers in Oncology|March 9, 2023
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case reportPierluigi di Mauro, Greta Schivardi, Rebecca Pedersini, et al.
Cancer Treatment Reviews|October 24, 2018
Systemic therapies in patients with advanced well-differentiated pancreatic neuroendocrine tumors (PanNETs): When cytoreduction is the aim. A critical review with meta-analysisMarta Pozzari, Patrick Maisonneuve, Francesca Spada, et al.
Oncology|April 6, 2005
A retrospective series of long-term survivors of metastatic breast cancer in complete remissionVito Amoroso, Francesca Valcamonico, Edda Simoncini, et al.
American Journal of Clinical Oncology|December 15, 2004
Epirubicin, cisplatin, and raltitrexed in patients with advanced gastric and hepatobiliary carcinoma: a phase II studyVittorio D Ferrari, Vito Amoroso, Francesca Valcamonico, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 2, 2008
Is irinotecan plus docetaxel useful as second-line therapy in advanced non-small cell lung cancer?Diego Cortinovis, Paolo Bidoli, Daniela Cullurà, et al.
BMJ Open|August 13, 2017
The involvement of early stage breast cancer patients during oncology consultations in Italy: a multi-centred, randomized controlled trial of a question prompt sheet versus question listingAlessandro Bottacini, Claudia Goss, Maria Angela Mazzi, et al.
Cancer Chemotherapy and Pharmacology|September 10, 2005
Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trialVittorio Ferrari, Francesca Valcamonico, Vito Amoroso, et al.
Endocrine-Related Cancer|November 14, 2025
Predictors of survival outcomes in patients with neuroendocrine neoplasms: a real-world retrospective studyMarta Laganà, Fabio Gallo, Maddalena Salvetti, et al.
Pageof 6